Abstract:Di Zeng, 1, &ast Wenbo Zhang, 2, &ast Xiaoju Chen, 3 Guochun Ou, 4 Yuewei Huang, 2 Chengxiu Yu 2 1 Department of General Practice, The Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, 637000, People's Republic of China; 2 Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, 637000, People's Republic of China; 3 Clinical Medical College, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, 610081, People's Republic of China; 4 Department of Respiratory and Critical Care Medicine, Suining Central Hospital, Suining, Sichuan, 629000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiaoju Chen, Clinical Medical College, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, 610081, People's Republic of China, Email Purpose: Here, we studied the pharmacological effect of P22077 on airway inflammation induced by lipopolysaccharide and cigarette smoke and explored the therapeutic mechanism of P22077 in COPD model RAT. Patients and Methods: The COPD model was established by lipopolysaccharide combined with fumigation; animals were treated with vehicle or P22077. Serum, bronchoalveolar lavage fluid (BALF), and lung tissues were collected for analysis. Results: Our results showed that P22077 treatment significantly improved the airway inflammation of COPD model RAT and reduced the recruitment of leukocytes in BALF, and hypersecretion of interleukin-18 (IL-18), interleukin-1β (IL-1β) in BALF and serum. H&E staining showed that P22077 treatment could effectively reduce emphysema, immune cell infiltration and airway wall destruction. PAS staining showed that The proliferation of cup cells in the airway wall and the number of bronchial cup cells were significantly reduced in rats treated with P22077. In addition, we found that P22077 treatment suppressed the generation of the NLRP3/ASC/Caspase 1 inflammasome complex to inhibit the inflammatory response caused by IL-1β and IL-18. Conclusion: Conclusion: P22077 inhibits expression of NLRP3 pathway-related inflammatory factors and proteins and reduces the airway inflammatory response and inflammatory cell aggregation in COPD rats. The underlying mechanism may be related to the down-regulation of NLRP3 inflammatory vesicle signaling pathway expression. Keywords: COPD, ubiquitinase inhibitors, P22077, airway inflammation, NLRP3 Chronic obstructive pulmonary disease (COPD) is one of the most common diseases of the respiratory system. COPD is a chronic inflammatory disease of the airways, lung parenchyma, and pulmonary vasculature caused by chronic infiltration of inflammatory cells from long-term exposure to harmful gases, dust, and other particles and complex interactions with the host's factors. The incidence and disease burden of COPD will increase in the coming decades because of ongoing exposure to risk factors caused by environmental and social health issues and an aging population worldwide. 1 By 2030, COPD will be the fourth leading cause of death worldwide and the seventh leading cause of the global burden of disease. 2 While studies on COPD are increasing, the pathogenesis of COPD is very complex and still not fully understood. Inflammation has been identified as one of the main causes of COPD onset and recurrent acute exacerbations. Even if the triggers of onset are removed, inflammation caused by an excessive or inadequate immune response will still persist and lead to chronic inflammation 3. Repeated irritation of the respiratory tract from various causes enriches inflammatory cells in the airways and lung tissue, stimulating the release of inflammatory mediators to trigger an inflammatory response, which becomes more pronounced and worsens with the development of disease. Inflammatory vesicles are closely related to the inflammatory response. 4 Currently, there are five types of inflammasome, among which the NLRP3 inflammasome is the one with the most attention and the most in-depth research. It consists of Nod-like receptor protein 3 as the receptor, ASC as the adaptor, and caspase-1 as the effector. 5 The recognition of danger signals by macrophages can lead to the aggregation of NLPR3 molecular complexes and the subsequent maturation of inflammatory vesicles and activation of caspase 1, leading to the release of cytokines such as IL-1β and IL-18 to participate in the inflammatory response. The roles of NLPR3 molecular complexes and the IL-1β and IL-18 cytokines in inflammatory diseases are gaining attention. The activation o -Abstract Truncated-

Pulmonary inflammation caused by cigarette smoke combined with lipopolysaccharide up-regulated OATP2B1 in rat lung tissue and pulmonary epithelial cells

Zl-n-91, a Selective Phosphodiesterase 4 Inhibitor, Suppresses Inflammatory Response in a COPD-like Rat Model.

Cigarette smoke extract combined with lipopolysaccharide reduces OCTN1/2 expression in human alveolar epithelial cells in vitro and rat lung in vivo under inflammatory conditions

WNT/β-catenin Signaling Regulates Cigarette Smoke-Induced Airway Inflammation Via the PPARδ/p38 Pathway

[Influence of Lipopolysaccharide on the Expression of Toll-like Receptor 4 in Human Bronchial Epithelium Cell in Patients with Chronic Obstructive Pulmonary Disease].

Cigarette Smoke or Motor Vehicle Exhaust Exposure Induces PD-L1 Upregulation in Lung Epithelial Cells in COPD Model Rats

Exposure to Cigarette Smoke Downregulatesβ2-Adrenergic Receptor Expression and Upregulates Inflammation in Alveolar Macrophages

Expression and significance of Toll-like receptor-4 in rats lung established by passive smoking or associated with intratracheal instillation of lipopolysaccharide

Cigarette Smoke-Induced Lung Inflammation in Copd Mediated Via Ltb4/Blt1/Socs1 Pathway

Therapeutic potential and mechanism of Dendrobium officinale polysaccharides on cigarette smoke-induced airway inflammation in rat

Effect of Cigarette Smoke Extraction on the Expression of Found in Inflammatory Zone 1 in Rat Lung Epithelial L2 Cells.

Cigarette smoke alters inflammatory genes and the extracellular matrix - investigations on viable sections of peripheral human lungs

Cigarette smoke exposure combined with lipopolysaccharides induced pulmonary fibrosis in mice.

Integrating 3-omics data analyze rat lung tissue of COPD states and medical intervention by delineation of molecular and pathway alterations

Cigarette smoke-induced lung inflammation in COPD mediated via CCR1/JAK/STAT /NF-κB pathway

Inhibitory Effect of P22077 on Airway Inflammation in Rats with COPD and Its Mechanism

Plasminogen Activator Inhibitor-1 Promotes Inflammatory Process Induced by Cigarette Smoke Extraction or Lipopolysaccharides in Alveolar Epithelial Cells.

Repeated exposure to hydrogen peroxide enhances TGF-ß and LPS dependent inflammatory responses in BEAS-2B cells

Cigarette smoke extract combined with LPS down-regulates the expression of MRP2 in chronic pulmonary inflammation may be related to FXR

Cigarette Smoke Induction of Osteopontin (SPP1) Mediates T(H)17 Inflammation in Human and Experimental Emphysema.

Effect of ozone exposure on airway inflammation and NF-κ B expression in lung tissue of COPD rats